Mammotome® Breast Biopsy System

The Mammotome® Breast Biopsy System is a technological advancement that assists physicians in obtaining the right amount of breast tissue for a definitive diagnosis without surgery. The Mammotome's ability to sample tiny abnormalities called microcalcifications-which can be the earliest or only sign of cancer-makes early detection and accurate diagnosis easier. You can be confident in your biopsy results because the Mammotome Breast Biopsy System is designed to accurately diagnose breast cancer at its earliest stages, when it is most treatable.

You will feel at ease during the procedure because a Mammotome biopsy causes little pain, requires no sutures, and can be performed quickly. Stereotactic (X-rays from two angles) or ultrasound (sound waves) images guide the Mammotome probe into the abnormal area and multiple tissue samples are removed.

Other biopsy options

Core Needle Biopsy: An earlier form of nonsurgical biopsy, called a core needle biopsy, is guided by stereotactic images and withdraws tissue through a spring-loaded device fired into the breast. A single sample is obtained each time the device is fired, so multiple insertions are needed to obtain sufficient breast tissue. Usually, 10 to 20 samples are taken.

Open Surgical Biopsy: Until the last few years, most biopsies were open surgical biopsies. First, a radiologist places a wire into the breast via mammography, locating the suspicious site. Then the surgeon, using the wire as a guide, makes an incision in the breast and removes a large section of tissue (about the size of a golf ball) for examination. Removal of such a large piece of tissue can permanently disfigure the breast. The surgery usually requires I day of recuperation at home.

Research supports Mammotome biopsies

Physicians have studied the Mammotome to document its effectiveness in the diagnosis of breast cancer. Key findings include: A 100 percent correlation exists between Mammotome biopsies and surgical biopsies in the diagnosis of two early-stage conditions: atypical ductal hyperplasia (AJDH), a benign condition that can sometimes become cancerous,, and ductal carcinoma in situ (DCIS), a cancer that has not spread. A Mammotome biopsy is 3 times more accurate than a core needle biopsy in diagnosing conditions associated with early stage breast cancer. The Mammotome is better at retrieving tiny abnormalities called microcalcifications than the core needle method.

Questions and answers about the Mammotome Breast Biopsy System.

Q: Is this an accepted procedure?

A: Yes. More than 270,000 Mammotome breast biopsy procedures have been performed. The Mammotome is available at 1,200 hospitals, clinics and breast centers in the United States.

Q: Will I feel any pain? Will I have a scar?

A: You will receive a small amount of local anesthesia and generally will not feel anything during the procedure. Your scar should be very small since only a skin nick is required to introduce the Mammotome probe.

Q: How can I get more information on the Mammotome?

A: Consult your physician, or call 1-888-298-9378 to receive additional information.